Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Sep 2025 is 1.34% vs 9.31% in Jun 2025
Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is 56.10% vs 129.08% in Jun 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Sep 2025 is 30.33% vs 335.71% in Jun 2025
Interest
QoQ Growth in quarter ended Sep 2025 is -31.71% vs -14.58% in Jun 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
Compare Quarterly Results Of Pharming Group NV With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2025 is 1.34% vs 9.31% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 22.32% vs 11.09% in Sep 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is 56.10% vs 129.08% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 811.11% vs -128.12% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is 30.33% vs 335.71% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 189.09% vs 34.15% in Sep 2024
Quarterly - Interest
QoQ Growth in quarter ended Sep 2025 is -31.71% vs -14.58% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 3.70% vs 0.00% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
YoY Growth in quarter ended Sep 2025 has improved from Sep 2024






